Market header image

Bulletins

You are here

2017-0204 - Suspension - Abattis Bioceuticals Corp. (ATT)

February 6, 2017

Abattis Bioceuticals Corp. is in default of CSE requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.  A cease trade order has been issued by the British Columbia Securities Commission and the Ontario Securities Commission.

Date: Effective immediately, February 6, 2017

Symbol: ATT

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com



CSE Listing(s):

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-07-11-Femmebought_-The-Virtual-Empowered-Purse-Gala_Website

Femmebought: The Virtual Empowered Purse Gala

Saturday, July 11, 2020 -
5:00pm to 7:30pm
2020-07-03-Tech-Tuesday_Transportation_Newsletter_Website

Tech Tuesdays

Tuesday, July 14, 2020 -
4:15pm to 5:00pm
07-15_Virtual_Industry_Updates_Tech_Strikes_Back_Website

Virtual Industry Updates: Tech Strikes Back

Wednesday, July 15, 2020 -
3:00pm to 4:15pm

Advertisement

Publicité